C96.2 - Malignant mast cell neoplasm

  • Applicable to Malignant mast cell neoplasm
  • The 2025 edition of ICD10-CM C96.2 became effective on October 1, 2024.
  • This is the American ICD10-CM version of C96.2 - other international versions of ICD10 C96.2 may differ.
  • C96.2 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • C96.2 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
  • C96.2 - Malignant mast cell neoplasm
    • C96.2 - Malignant mast cell neoplasm
    • C96.20 - Malignant mast cell neoplasm, unspecified
    • C96.21 - Aggressive systemic mastocytosis
    • C96.22 - Mast cell sarcoma
    • C96.29 - Other malignant mast cell neoplasm

Type 1 Excludes

  • indolent mastocytosis (D47.02)
  • mast cell leukemia (C94.30)
  • mastocytosis (congenital) (cutaneous) (Q82.2)

The following codes above C96.2 contain annotation back-references that may be applicable to C96.2:

Chapter: C00-D49 Neoplasms

Section: C81-C96 Malignant neoplasms of lymphoid, hematopoietic and related tissue

Category: C96 Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

  
Non-Billable/Non-Specific Code

Browse other similar CM codes

            

Please, give attribution to our website icd-10code.com